CMS Keeps “Functional Equivalence” In 2004; Amgen Submits Aranesp Data

Amgen has submitted data to the Centers for Medicare & Medicaid Services suggesting reimbursement for Aranesp should be increased by more than 50% in the final 2004 Hospital Outpatient Prospective Payment System rule